arrow
H

Hieronymus D. Boogaarts

Medical University Sofia
H指数:38
被引数:4,841

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Quality of life after tranexamic acid in subarachnoid hemorrhage: post-hoc analysis of the ULTRA trial

蛛网膜下腔出血中使用氨甲环酸后的生活质量:ULTRA试验的事后分析

2026-05-030
OA
Cost-Effectiveness of Ultra-Early Tranexamic Acid as Add-On to Standard Care After Subarachnoid Hemorrhage (ULTRA Trial)

超早期氨甲环酸作为蛛网膜下腔出血后标准护理的附加治疗的经济性分析(ULTRA试验)

2025-08-220
OAAI
National trends in patient characteristics, interventional techniques and outcomes of endovascular treatment for acute ischaemic stroke: Final results of the MR CLEAN Registry (2014-2018)

急性缺血性卒中经导管血管内治疗的患者特征、干预技术和结局的全国趋势:MR CLEAN Registry(2014-2018)的最终结果

2025-05-020
PRE
Incidence, case fatality, and functional outcome of intracerebral haemorrhage, according to age, sex, and country income level: a systematic review and meta-analysis

根据年龄、性别和国家收入水平的颅内出血发病率、病死率和功能结局:一项系统评价和荟萃分析

2025-02-012
OAAI
Ultra-Early and Short-Term Tranexamic Acid Treatment in Patients With Good- and Poor-Grade Aneurysmal Subarachnoid Hemorrhage
2024-06-253
OAAI
Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial

荷兰缺血性卒中患者CT血管造影 (MR CLEAN-LATE) 6 ~ 24 h后血管内治疗与未血管内治疗的比较: 一项多中心、开放标签、盲法终点、随机、对照、3期临床试验

LANCET
IF88.5
2023-04-0195
OAAI